Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Einzigartiges Zentrum
Centre for Addiction and Mental Health
Toronto, CanadáPublikationen in Zusammenarbeit mit Forschern von Centre for Addiction and Mental Health (2)
2020
-
Association of BDNF, HTR2A, TPH1, SLC6A4, and comt polymorphisms with tdcs and escitalopram efficacy: Ancillary analysis of a double-blind, placebo-controlled trial
Brazilian Journal of Psychiatry, Vol. 42, Núm. 2, pp. 128-135
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114